Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0X6MO
|
||||
| Former ID |
DIB013431
|
||||
| Drug Name |
Ralitoline
|
||||
| Synonyms |
GO-4942; Goe-4942; PD-117818
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Epilepsy [ICD10:G40] | Terminated | [545466] | ||
| Company |
Parke-Davis & Co
|
||||
| Formula |
C13H13ClN2O2S
|
||||
| Canonical SMILES |
C\1(=C\C(=O)Nc2c(Cl)cccc2C)/N(C(=O)CS1)C
|
||||
| CAS Number |
CAS 93738-40-0
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Modulator | [526758] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.